If an AI-assistance leads to a product quality defect, plaintiffs might claim negligence in relying on an imperfect algorithm. FDAs stance provides a strong defense: the regulation itself (and its warning letter) emphasizes that the company not the AI is liable for the outcome
However, it is important to note glycosylation patterns and glycan species can vary in different cell types 15 and are altered in malignant cells compared to non-malignant cells 16
Members who are denied coverage can seek a hearing, the department said in a letter to members
The panel agreed that initial treatment should be parenteral for severe cases, while high-dose oral B12 can be considered for maintenance
However, when combined with sulphonylureas or insulin, the risk increases significantly, and doses of these medications may need reduction under clinical supervision to prevent low blood glucose and associated dizziness
See Important Safety Information about GLP-1 medications, including Boxed Warning, at ro.co/safety